Tower Research Capital »

Hemab Therapeutics Holdings shares owned by Tower Research Capital

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $37 1 37.00

More positions owned by Tower Research Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Spdr Series Trust St Inter Bd Etf (SPIB)
Micron Technology (MU)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Intel Corporation (INTC)
Ishares Tr 0-3 Mth Treasury (SGOV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Tower Research Capital

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
Deep Track Capital
Siren
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
BlackRock

View all funds holding Hemab Therapeutics Holdings